About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Himalaya Therapeutics publishes data on cancer treatment

Aldatu gets grant to develop Crimean Congo hemorrhagic fever test

Scope Biosciences and WUR to improve CRISPR-Cas technology with new funds

PDC*line Pharma presents results from phase I/II trial

Enterome presents more data on therapeutic cancer treatment

Astellas, Seagen and Merck give details on urothelial cancer treatment

ADVERTISEMENT

Could combining biotech and photosynthetic cyanobacteria help the energy crisis?

Ayala Pharmaceuticals presents interim data on desmoid tumor trial

Reveal Genomics reveals more HER2DX breast cancer validation data

SiSaf reveals positive preclinical data in siRNA program to treat osteopetrosis

Shasqi moves to phase 2 solid tumor study

Liquid-interface assisted SERS could lead to earlier detection of Alzheimer’s

ADVERTISEMENT